Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Circulation|October 6, 1999
Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wallY F Zhou, M Shou, E Guetta, et al.
Biochemical Pharmacology|November 27, 1995
Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4H V Gelboin, K W Krausz, I Goldfarb, et al.
The American Journal of Physiology|April 1, 1994
Basic fibroblast growth factor enhances myocardial collateral flow in a canine modelE F Unger, S Banai, M Shou, et al.
Neuroscience|March 21, 2008
Up-regulation of GLT1 expression increases glutamate uptake and attenuates the Huntington's disease phenotype in the R6/2 mouseB R Miller, J L Dorner, M Shou, et al.
Journal of the American College of Cardiology|February 17, 2000
Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogsM A Rajanayagam, M Shou, V Thirumurti, et al.
Journal of the American College of Cardiology|April 1, 1997
Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vesselsM Shou, V Thirumurti, S Rajanayagam, et al.
Circulation|January 1, 1995
Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heartD F Lazarous, M Scheinowitz, M Shou, et al.
Molecular Carcinogenesis|December 1, 1996
Specificity of cDNA-expressed human and rodent cytochrome P450s in the oxidative metabolism of the potent carcinogen 7,12-dimethylbenz[a]anthraceneM Shou, K R Korzekwa, K W Krausz, et al.
Journal of the American College of Cardiology|May 10, 2001
Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemiaS Fuchs, R Baffour, Y F Zhou, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 17, 2001
Role of human liver cytochrome P4503A in the metabolism of etoricoxib, a novel cyclooxygenase-2 selective inhibitorK Kassahun, I S McIntosh, M Shou, et al.
Pageof 8